O-017FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO. (20th June 2018)

Record Type:
Journal Article
Title:
O-017FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO. (20th June 2018)
Main Title:
O-017FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO
Authors:
Marmorino, F
Cremolini, C
Bergamo, F
Pella, N
Antoniotti, C
Rossini, D
Dell'Aquila, E
Masi, G
Salvatore, L
Loupakis, F
Marcucci, L
Gemma, D
Cardellino, G
Borelli, B
Ricci, V
Delfanti, S
Mori, E
Tonini, G
Lonardi, S
Fontanini, G
Boni, L
Falcone, A
Abstract:
Is Part Of:
Annals of oncology. Volume 29(2018)Supplement 5
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Issue Display:
Volume 29, Issue 5 (2018)
Year:
2018
Volume:
29
Issue:
5
Issue Sort Value:
2018-0029-0005-0000
Page Start:
Page End:
Publication Date:
2018-06-20
Subjects:
Oncology -- Periodicals
616.992
Journal URLs:
https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:
10.1093/annonc/mdy149.016 ↗
Languages:
English
ISSNs:
0923-7534
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
12263.xml